iBio Inc. has announced that it received a notification from the Nasdaq Stock Market LLC regarding non-compliance with the minimum bid price requirement. For the past 30 consecutive business days, the company's stock has not maintained a minimum closing bid price of $1.00 per share, as required by Nasdaq Listing Rule 5550(a)(2). While this notice does not immediately affect the listing or trading of iBio's common stock, the company has been given a 180-day compliance period, ending on January 26, 2026, to rectify the issue. iBio plans to monitor its stock price and explore options, such as a reverse stock split, to meet the Nasdaq requirements and avoid potential delisting. If necessary, the company may seek additional time beyond the initial compliance period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.